Celsius Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 64

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $250M

Celsius Therapeutics General Information

Description

Developer of medicines designed to treat complex diseases such as autoimmunity and cancer. The company's medicines apply a systematic approach to single-cell sequencing, combining massive datasets and algorithms in order to discover precision therapies, enabling doctors to identify genes that causally contribute to disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 245 First Street
  • 18th Floor
  • Cambridge, MA 02142
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celsius Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Jun-2024 $250M Completed Clinical Trials - Phase 1
2. Early Stage VC (Series B) 24-Mar-2022 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 15-May-2018 $65M $65M Completed Startup
To view Celsius Therapeutics’s complete valuation and funding history, request access »

Celsius Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Celsius Therapeutics’s complete cap table history, request access »

Celsius Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medicines designed to treat complex diseases such as autoimmunity and cancer. The company's medicines apply
Discovery Tools (Healthcare)
Cambridge, MA
64 As of 2023

Farmington, CT
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celsius Therapeutics Competitors (78)

One of Celsius Therapeutics’s 78 competitors is Intus Biosciences, a Venture Capital-Backed company based in Farmington, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intus Biosciences Venture Capital-Backed Farmington, CT
Ventus Therapeutics Venture Capital-Backed Waltham, MA
Enterome Venture Capital-Backed Paris, France
CaroGen Venture Capital-Backed Farmington, CT
Aegle Therapeutics Venture Capital-Backed Woburn, MA
You’re viewing 5 of 78 competitors. Get the full list »

Celsius Therapeutics Patents

Celsius Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024257984-A1 Anti-trem1 antibody agents, compositions, and uses thereof Pending 21-Apr-2023
EP-4562056-A1 Anti-trem1 antibody agents, compositions, and uses thereof Pending 21-Apr-2023
US-20260242465-A1 Anti-trem1 antibody agents, compositions, and uses thereof Pending 21-Apr-2023
WO-2024220958-A1 Anti-trem1 antibody agents, compositions, and uses thereof Inactive 21-Apr-2023
WO-2024220958-A9 Anti-trem1 antibody agents, compositions, and uses thereof Inactive 21-Apr-2023 C07K16/2803
To view Celsius Therapeutics’s complete patent history, request access »

Celsius Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celsius Therapeutics Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Amgen Ventures Corporate Venture Capital Minority
Amplitude Ventures Venture Capital Minority
Casdin Capital Venture Capital Minority
Catalio Capital Management Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Celsius Therapeutics FAQs

  • When was Celsius Therapeutics founded?

    Celsius Therapeutics was founded in 2018.

  • Where is Celsius Therapeutics headquartered?

    Celsius Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Celsius Therapeutics?

    Celsius Therapeutics has 64 total employees.

  • What industry is Celsius Therapeutics in?

    Celsius Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Celsius Therapeutics a private or public company?

    Celsius Therapeutics is a Private company.

  • What is the current valuation of Celsius Therapeutics?

    The current valuation of Celsius Therapeutics is .

  • What is Celsius Therapeutics’s current revenue?

    The current revenue for Celsius Therapeutics is .

  • How much funding has Celsius Therapeutics raised over time?

    Celsius Therapeutics has raised $148M.

  • Who are Celsius Therapeutics’s investors?

    Alexandria Venture Investments, Amgen Ventures, Amplitude Ventures, Casdin Capital, and Catalio Capital Management are 5 of 11 investors who have invested in Celsius Therapeutics.

  • Who are Celsius Therapeutics’s competitors?

    Intus Biosciences, Ventus Therapeutics, Enterome, CaroGen, and Aegle Therapeutics are some of the 78 competitors of Celsius Therapeutics.

  • When was Celsius Therapeutics acquired?

    Celsius Therapeutics was acquired on 27-Jun-2024.

  • Who acquired Celsius Therapeutics?

    Celsius Therapeutics was acquired by AbbVie.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process